on 4 Apr 2024
TM5 Status
LIVE/REGISTRATION/Issued and Active
Your registration has been issued and is active. You can now use the TM5 mark.
Last Applicant/ Owned by
CSL BEHRING GMBH
Emil-von-Behring Str. 7635041 Marburg
DE
Serial Number
2156413 filed on 29th Nov 2021
Registration Number
TMA1227998 registered on 4th Apr 2024
Registration expiry Date
29th Nov 2031Correspondent Address
GOWLING WLG (CANADA) LLP
SUITE 2600, 160 ELGIN STREETOTTAWA
ONTARIO
CA
K1P1C3
Trademark usage description
pharmaceutical preparations for the treatment of blood disorders; pharmaceutical preparations for the treatment of respiratory diseases, disorders and Read More11
2156413
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 22 on 28th Mar 2023 | Search Recorded |
Submitted for opposition 20 on 28th Mar 2023 | Examiner's First Report |
Submitted for opposition 223 on 28th Mar 2023 | Total Provisional Refusal |
Submitted for opposition 256 on 24th Oct 2022 | Notification of Possible Opposition Sent |
Submitted for opposition 48 on 25th Jul 2022 | Agent Changed |
Submitted for opposition 257 on 23rd Dec 2021 | Designation Notification - Madrid Protocol |
Submitted for opposition 31 on 22nd Dec 2021 | Formalized |
Submitted for opposition 1 on 22nd Dec 2021 | Created |
Submitted for opposition 228 on 29th Nov 2021 | International Registration |
Submitted for opposition 30 on 29th Nov 2021 | Filed |
This website uses cookies
Manage cookies
You can choose to enable or disable some or all of these cookies but disabling some of them may affect your browsing experience.
Advertisement
Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously
Analytics
Analytical cookies are used to understand how visitors interact with the website.
Functional
Functional cookies help perform certain functionalities like collecting feedback, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website.